Tbx20 Is Required in Mid-Gestation Cardiomyocytes and Plays a Central Role in Atrial Development
Year: 2018
Type: article
Abstract: RATIONALE: Mutations in the transcription factor TBX20 (T-box 20) are associated with congenital heart disease. Germline ablation of Tbx20 results in abnormal heart development and embryonic lethality by embryonic day 9.5. Because Tbx20 is expressed in multiple cell lineages required for myocardial development, including pharyngeal endoderm, cardiogenic mesoderm, endocardium, and myocardium, the cell type-specific requirement for TBX20 in early myocardial development remains to be explored. OBJECTIVE: Here, we investigated roles of TBX20 in midgestation cardiomyocytes for heart development. METHODS AND RESULTS: Ablation of Tbx20 from developing cardiomyocytes using a doxycycline inducible cTnTCre transgene led to embryonic lethality. The circumference of developing ventricular and atrial chambers, and in particular that of prospective left atrium, was significantly reduced in Tbx20 conditional knockout mutants. Cell cycle analysis demonstrated reduced proliferation of Tbx20 mutant cardiomyocytes and their arrest at the G1-S phase transition. Genome-wide transcriptome analysis of mutant cardiomyocytes revealed differential expression of multiple genes critical for cell cycle regulation. Moreover, atrial and ventricular gene programs seemed to be aberrantly regulated. Putative direct TBX20 targets were identified using TBX20 ChIP-Seq (chromatin immunoprecipitation with high throughput sequencing) from embryonic heart and included key cell cycle genes and atrial and ventricular specific genes. Notably, TBX20 bound a conserved enhancer for a gene key to atrial development and identity, COUP-TFII/Nr2f2 (chicken ovalbumin upstream promoter transcription factor 2/nuclear receptor subfamily 2, group F, member 2). This enhancer interacted with the NR2F2 promoter in human cardiomyocytes and conferred atrial specific gene expression in a transgenic mouse in a TBX20-dependent manner. CONCLUSIONS: Myocardial TBX20 directly regulates a subset of genes required for fetal cardiomyocyte proliferation, including those required for the G1-S transition. TBX20 also directly downregulates progenitor-specific genes and, in addition to regulating genes that specify chamber versus nonchamber myocardium, directly activates genes required for establishment or maintenance of atrial and ventricular identity. TBX20 plays a previously unappreciated key role in atrial development through direct regulation of an evolutionarily conserved COUPT-FII enhancer.
Source: Circulation Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Funders: American Heart Association, European Commission, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, National Institutes of Health, University of California, San Diego, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke, School of Medicine, University of California, San Diego
Awards: Adipocytes and cardiac remodeling, G1617165148, G1712855090, Mechanisms of Islet1 Action in Heart Development, BAG3 in Cardiac function and disease, G3033040839, G3115552502, Transcriptional Control of Cardiac Conduction System Function by T-box Genes, Luma in Cardiac Function and Disease, Endocardial Pathways Regulated by Tbx20, Identification of novel mechanisms underlying congenital heart defects by tissue specific inactivation of T-box transcription factor Tbx20., Cardiomyopathy Genomes Project, University of California San Diego Neuroscience Microscopy Imaging Core, Functional Genomics of IL-33 expression and asthma risk, Molecular dissection of titin-based mechanisms in charge of cardiomyocyte dysfunction in terminal feart failure, The Role of Dot1L in developing and postnatal heart, The Role of Tbox20 in Cardiac Development & Adult Heart, Approaches to Cardiac Regeneration, Functional Assays to Screen Genomic Hits, G9000254353, Cardiovascular Sciences Training Grant
OpenAlex ID: W2808069094
